UFlex is the first and only Indian company to receive USFDA approval for its technology and capacity to recycle all three materials
The company received one observation in the Form-483
Innovative agents highlight growth of targeted protein degradation platform and BMS' leadership in innovative cancer therapies
The companies aim to create customized AI models and agents that Novo Nordisk can use for early research and clinical development
The project will be instrumental in enhancing the company's API manufacturing capacity and global reach
The company received 1 (One) observation in the Form-483
25 women students to receive internship, training, and mentorship in Life Sciences segment
The acquisition sets up the foundation for a central hub of GMP value-added services and greater access to new customers in the rapidly growing Biopharma market
This project builds on a previous joint funding agreement between CARBOGEN AMCIS and the same customer in April 2021
Oxcarbazepine ER Tablets (RLD Oxtellar XR) had estimated annual sales of US$ 206 million in the US (IQVIA MAT April 2025)
Subscribe To Our Newsletter & Stay Updated
